CN1769468A - Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum - Google Patents
Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum Download PDFInfo
- Publication number
- CN1769468A CN1769468A CN 200510100338 CN200510100338A CN1769468A CN 1769468 A CN1769468 A CN 1769468A CN 200510100338 CN200510100338 CN 200510100338 CN 200510100338 A CN200510100338 A CN 200510100338A CN 1769468 A CN1769468 A CN 1769468A
- Authority
- CN
- China
- Prior art keywords
- culture
- cultivation
- medium
- epothilone
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种利用纤维堆囊菌高效生产埃博霉素的方法。本发明通过对纤维堆囊菌的发酵培养基进行改良,并添加环式糊精或环式糊精的衍生物到发酵培养基中,使得发酵培养基更加适合菌体生长,埃博霉素的产量更高。The invention discloses a method for efficiently producing epothilone by using S. cellulosus. The present invention improves the fermentation medium of S. cellulosus, and adds cyclodextrin or cyclodextrin derivatives to the fermentation medium, so that the fermentation medium is more suitable for cell growth, and the epothilone Yield is higher.
Description
技术领域technical field
本发明涉及微生物领域,具体的说涉及一种埃博霉素的高效生产方法。The invention relates to the field of microorganisms, in particular to a high-efficiency production method of epothilone.
背景技术Background technique
粘细菌(Myxobacteria)是最高等的革兰氏阴性原核生物类群,具有复杂的多细胞行为,在细胞分化、发育和生物进化研究中占有重要地位。粘细菌可产生异常丰富的次级代谢产物,而且产物生物活性作用的多样性可以与著名的链霉菌类群相比拟,在微生物新药的开发研究中是极好的菌种资源。Myxobacteria (Myxobacteria) are the highest Gram-negative prokaryotic group, with complex multicellular behavior, occupying an important position in the study of cell differentiation, development and biological evolution. Myxobacteria can produce extremely rich secondary metabolites, and the diversity of biological activity of the products can be compared with the famous Streptomyces group, which is an excellent strain resource in the development and research of new microbial drugs.
纤维堆囊菌(Sorangium cellulosum)属于粘细菌的溶纤维素类群,它产生的大环类酯类化合物埃博霉素(epothilone)具有促微管聚合的活性,是目前引起医药界广泛关注的抗癌物质。Epothilone能与真核细胞中的微管骨架结合,导致染色体分离受阻,细胞核不能分裂,作用的有效浓度为10~20ng/ml。Sorangium cellulosum belongs to the cellulolytic group of myxobacteria, and the macrocyclic ester compound epothilone (epothilone) produced by it has the activity of promoting microtubule polymerization. carcinogen. Epothilone can combine with the microtubule skeleton in eukaryotic cells, resulting in blocked chromosome segregation and inability to divide the nucleus. The effective concentration of the effect is 10-20ng/ml.
Epothilone最早在纤维堆囊菌Sorangium cellulosum90菌株中发现。是由纤维素堆囊菌(Sorangium cellulosum)分泌的一类大环内酯类化合物,目前发现有两种天然衍生物,分别称为埃博霉素A(分子式C26H39NO6S)与埃博霉素B(分子式为C27H39NO6S),分子结构如式(I)所示。它们的外观如无色的油,在乙酸乙酯中结晶形成粉末。Epothilone was first discovered in Sorangium cellulosum90 strain. It is a class of macrocyclic lactone compounds secreted by Sorangium cellulosum. Two natural derivatives have been found, which are called epothilone A (molecular formula C 26 H 39 NO 6 S) and Epothilone B (molecular formula is C 27 H 39 NO 6 S), the molecular structure is shown in formula (I). They appear as colorless oils which crystallize in ethyl acetate to form powders.
埃博霉素(Epothilones)有与紫杉醇(Taxol)相似的作用机制,对治疗癌症有较好的疗效。但Epothilones与紫杉醇相比有如下优点。Epothilones have a similar mechanism of action to Taxol, and have a better curative effect on cancer treatment. But Epothilones has the following advantages compared with paclitaxel.
1.Epothilones的结构比紫杉醇更为简单,其离体抑制的效果比紫杉醇强2000~5000倍,并且带甲基的B的作用效果比A基本上大2倍。1. The structure of Epothilones is simpler than that of paclitaxel, and its inhibitory effect in vitro is 2000-5000 times stronger than that of paclitaxel, and the effect of B with a methyl group is basically 2 times greater than that of A.
2.Epothilones有更好的水溶性,且更易通过发酵来获得。2. Epothilones have better water solubility and are easier to obtain through fermentation.
3.Epothilones不是P2糖蛋白的底物,对多药耐药细胞有很强的细胞毒性。因而埃博霉素的抗肿瘤性能不但要比紫杉醇的强得多,而且其抗肿瘤谱可能广得多。Epothilones有显著选择性的抗乳腺肿瘤细胞与结肠肿瘤细胞的活性。3. Epothilones are not substrates of P2 glycoprotein, and have strong cytotoxicity to multidrug-resistant cells. Therefore, the anti-tumor performance of epothilone is not only much stronger than that of paclitaxel, but also its anti-tumor spectrum may be much wider. Epothilones have significant selective activity against breast tumor cells and colon tumor cells.
4.施用紫杉醇会伴随一些临床的副作用(如中性白细胞减少症、外周神经病变、脱发与过敏反应)。4. The administration of paclitaxel will be accompanied by some clinical side effects (such as neutropenia, peripheral neuropathy, alopecia and allergic reaction).
目前已有一些关于纤维堆囊菌株在发酵罐进行发酵合成Epothilones的实验的报道,以及关于影响Epothilones合成的营养控制的研究,但是现有Epothilones的生产方法普遍存在产量不稳定以及其产量偏低等问题。At present, there are some reports about the experiments of the cellulocomplexus strains fermenting and synthesizing Epothilones in fermenters, and the research on the nutritional control affecting the synthesis of Epothilones, but the production methods of the existing Epothilones generally have unstable yields and low yields, etc. question.
为了达到Epothilones用于制药的目的,就必须得到足够量的含有Epothilones的发酵液混合物。至今为止,在粘细菌特别是其Soce90菌株中提取Epothiliones已经在文献中有所报道。为了能提取到相对高浓度的Epothilones,以前在即将提取的发酵培养基中经常加入以聚苯乙烯为材料的树脂,例如AmberliteXAD-1180。然而这种方法的缺点在于,在大规模的应用中会引发一系列的问题。发酵罐的阀门会被树脂小球损害;管道可能会堵塞并且仪器可能会由于机械摩擦力而导致更大的磨损。树脂是多孔渗水物质,因此会有较大的内表面积(大约825m2/g),在高压灭菌的过程中,内部的空气就无法一起被灭菌。所以在实际大规模应用中,就不能用添加树脂的方法。但是,如果不添加树脂,在发酵培养基中又难以提取到较高浓度的Epothiliones。In order to achieve the purpose of Epothilones being used in medicine, it is necessary to obtain a sufficient amount of fermentation broth mixture containing Epothilones. So far, the extraction of Epothiliones in myxobacteria, especially its Soce90 strain, has been reported in the literature. In order to extract relatively high concentrations of Epothilones, resins made of polystyrene, such as AmberliteXAD-1180, were often added to the fermentation medium to be extracted. However, the disadvantage of this method is that it will cause a series of problems in large-scale applications. The valves of the fermenter can be damaged by resin pellets; the pipes can become clogged and the instruments can experience greater wear due to mechanical friction. Resin is a porous material, so it will have a large internal surface area (about 825m2/g). During the autoclaving process, the internal air cannot be sterilized together. Therefore, in actual large-scale applications, the method of adding resin cannot be used. However, if no resin is added, it is difficult to extract higher concentrations of Epothiliones in the fermentation medium.
目前为止,从粘细菌中获得Epothiliones并应用于工业技术生产领域而又没有上述缺点的方法,仍处于寻求阶段。So far, the method of obtaining Epothiliones from myxobacteria and applying it to the field of industrial technology production without the above-mentioned disadvantages is still in the seeking stage.
发明内容Contents of the invention
本发明的目的在于针对现有埃博霉素生产方法存在的各种问题,提供一种利用纤维堆囊菌高效生产埃博霉素的方法。The purpose of the present invention is to provide a method for efficient production of epothilones by using S. cellulosus to solve various problems in the existing epothilone production methods.
纤维堆囊菌购于German Collection of Microorganisms and Cell Cultures(DSMZ,Brauuschweig,Germany),通过对其发酵培养基进行改良,并添加环式糊精或环式糊精的衍生物到发酵培养基中,使得发酵培养基更加适合菌体生长,Epothiliones的产量更高。由于环式糊精分子内存在疏水的空穴,而分子外亲水,这样不仅可以吸附产物同时不影响菌体的生长,还可以减弱产物抑制的现象。此外能将Epothiliones从发酵液中提取出来。S. cellulosus was purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ, Brauuschweig, Germany), by improving its fermentation medium and adding cyclodextrin or cyclodextrin derivatives to the fermentation medium, The fermentation medium is more suitable for cell growth, and the yield of Epothiliones is higher. Since there are hydrophobic cavities inside the cyclodextrin molecule, while the outside of the molecule is hydrophilic, it can not only adsorb the product without affecting the growth of the bacteria, but also weaken the phenomenon of product inhibition. In addition, Epothiliones can be extracted from the fermentation broth.
本发明利用纤维堆囊菌生产埃博霉素的方法,具体包括如下步骤:The present invention utilizes S. cellulosus to produce the method for epothilone, specifically comprises the following steps:
(1)前培养:将已灭菌的培养基G52加入到摇瓶中,然后接入纤维堆囊菌到摇瓶中培养,培养时间为3~4天,培养条件为:120~250rpm,29~31℃;(1) Pre-cultivation: Add the sterilized medium G52 into the shake flask, and then insert S. cellulosus into the shake flask for cultivation. The cultivation time is 3-4 days. The cultivation conditions are: 120-250rpm, 29 ~31°C;
所述培养基G52为:The culture medium G52 is:
干酵母粉 2g/L
MgSO4 1g/LMgSO 4 1g/L
CaCl2 1g/LCaCl 2 1g/L
脱脂奶粉 2g/L
马铃薯淀粉 88/L Potato Starch
无水葡萄糖 2g/LDextrose Anhydrous 2g/L
EDTA-Fe(III)-Na 1ml/LEDTA-Fe(III)-Na 1ml/L
调pH至7.4,120℃灭菌20分钟;Adjust the pH to 7.4, and sterilize at 120°C for 20 minutes;
前培养的目的在于活化菌种,培育菌种。The purpose of the pre-cultivation is to activate the strains and cultivate the strains.
(2)中间培养:将已灭菌的培养基G52加入到发酵槽中,然后接入前培养物到发酵槽中培养,培养时间为3~4天,培养条件为:29~31℃,200~300rpm,通风量为每升液体培养基每分钟0.5升空气,120~122℃,pH7.4;中间培养的目的在于使菌种生长进入对数生长期,为接下来的发酵培养做好准备。(2) Intermediate cultivation: Add the sterilized medium G52 into the fermenter, and then put the pre-culture into the fermenter for cultivation. The cultivation time is 3 to 4 days. The cultivation conditions are: 29~31°C, 200°C ~300rpm, the ventilation rate is 0.5 liters of air per liter of liquid medium per minute, 120~122℃, pH7.4; the purpose of the intermediate culture is to make the growth of the bacteria enter the logarithmic growth phase and prepare for the next fermentation culture .
(3)发酵培养:在发酵罐中加入已灭菌的1B12改良培养基,接着加入已灭菌的环式糊精或其衍生物,然后将中间培养物接入发酵罐中培养,培养时间为6~7天,培养条件为:20~35℃,120~250rpm,即可得到含有埃博霉素的发酵液;环式糊精及其衍生物的添加是以其水溶液形式添加的,糊精及其衍生物添加的量为:1克糊精或其衍生物/每100ml发酵液。添加的糊精或其衍生物溶液体积为整个发酵液体积的10%。发酵液的体积包括培养基体积、糊精溶液体积和中间培养物体积。(3) Fermentation culture: Add sterilized 1B12 improved medium into the fermenter, then add sterilized cyclodextrin or its derivatives, then insert the intermediate culture into the fermenter for cultivation, and the cultivation time is After 6-7 days, the culture conditions are: 20-35°C, 120-250rpm, and the fermentation broth containing epothilone can be obtained; cyclodextrin and its derivatives are added in the form of its aqueous solution, dextrin The amount of dextrin and its derivatives added is: 1 gram of dextrin or its derivatives/per 100ml fermentation broth. The volume of the added dextrin or its derivative solution is 10% of the volume of the whole fermentation broth. The volume of the fermentation broth includes medium volume, dextrin solution volume and intermediate culture volume.
所述1B12改良培养基为:The 1B12 improved medium is:
马铃薯淀粉 20g/LPotato starch 20g/L
胰蛋白胨 11g/L
MnCl4 1mg/LMnCl 4 1mg/L
K2HPO4 0.06g/LK 2 HPO 4 0.06g/L
ZnCl2 1mg/L ZnCl2 1mg/L
CuSO4 1mg/LCuSO 4 1mg/L
EDTA-Fe(III)-Na 8mg/LEDTA-Fe(III)-Na 8mg/L
调pH至7.8,120℃灭菌20分钟。 Adjust the pH to 7.8 and sterilize at 120°C for 20 minutes.
上述步骤(3)所述发酵培养在发酵的第三天加入添加4mg/L氨基酸和4mg/L生长因子。最佳的氨基酸是丙氨酸,最佳的生长因子是乙酸钾。For the fermentation culture described in the above step (3), 4 mg/L amino acid and 4 mg/L growth factor were added on the third day of fermentation. The best amino acid is alanine, and the best growth factor is potassium acetate.
上述步骤(1)所述前培养的最佳培养条件是:180rpm,30℃,摇瓶位移50mm。The optimal culture conditions for the pre-cultivation in the above step (1) are: 180 rpm, 30° C., and a shaker flask displacement of 50 mm.
上述步骤(2)所述中间培养的最佳培养条件是:30℃,250rpm,通风量为每升液体培养基每分钟0.5升空气,121℃,pH7.4。The optimal culture conditions for the intermediate culture in the above step (2) are: 30° C., 250 rpm, ventilation rate of 0.5 liter of air per minute per liter of liquid medium, 121° C., pH 7.4.
上述步骤(3)所述发酵培养的最佳培养条件是:25℃,180rpm,pH7.8。The optimal culture conditions for the fermentation culture in the above step (3) are: 25° C., 180 rpm, pH 7.8.
上述生产埃博霉素的方法,还包括埃博霉素的分离纯化,其方法为①发酵液经离心、过滤,得到的滤液与树脂按体积比65∶1,搅拌混合,离心,得到的树脂先用去离子水洗涤,然后用异丙醇洗涤,得到的洗涤液中加入水,萃取其中的异丙醇,剩下的水相中再用乙酸乙酯萃取,得到的乙酸乙酯萃取物在真空旋转蒸发器中浓缩、干燥,即可得粗结晶。将所得粗结晶加入异丙醇中,振荡,过滤,然后在真空干燥器中干燥,得到epothilones B白色晶体;对所得白色晶体进一步通过反相色谱柱RP-18柱纯化,乙腈作为洗脱液,最后用乙酸乙酯∶甲苯=2∶3的混合液来结晶,即可得到epothilone A。The above-mentioned method for producing epothilones also includes the separation and purification of epothilones. The method is as follows: (1) the fermentation broth is centrifuged and filtered, and the obtained filtrate and resin are mixed at a volume ratio of 65:1, stirred and mixed, centrifuged, and the obtained resin First wash with deionized water, then wash with isopropanol, add water to the washing liquid obtained, extract the isopropanol therein, and then extract with ethyl acetate in the remaining water phase, the ethyl acetate extract obtained is in Concentrate and dry in a vacuum rotary evaporator to obtain crude crystals. Gained crude crystals are added in isopropanol, vibrated, filtered, and then dried in a vacuum desiccator to obtain epothilones B white crystals; the resulting white crystals are further purified by reverse-phase chromatographic column RP-18, and acetonitrile is used as eluent. Finally, crystallize with ethyl acetate:toluene=2:3 mixture to obtain epothilone A.
本发明与现有技术相比,具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1.本发明在发酵液中添加了环式糊精,由于环式糊精分子内存在疏水的空穴,而分子外亲水,这样不仅可以吸附产物同时不影响菌体的生长,还可以减弱产物抑制的现象。1. In the present invention, cyclodextrin is added to the fermentation broth. Because there are hydrophobic cavities in the cyclodextrin molecule, while the outside of the molecule is hydrophilic, it can not only adsorb the product without affecting the growth of the bacteria, but also weaken the Phenomenon of product inhibition.
2.本发明改良了Epothilone的发酵培养基的成分,并且对发酵条件液进行了改良,使其更适合Epothilone的产生,提高了产量。2. The present invention improves the composition of the fermentation medium of Epothilone, and improves the fermentation condition liquid, makes it more suitable for the production of Epothilone, and improves the output.
3.本发明在发酵完毕进行提取时才加入树脂XAD-16吸附产物,有效的得到了较高浓度的Epothilone。3. In the present invention, the resin XAD-16 adsorption product is added only when the fermentation is completed and the extraction is carried out, and a higher concentration of Epothilone is effectively obtained.
具体实施方式Detailed ways
一般种子液的接种量为10%(V/V),发酵液的接种量为20%(V/V)。需要注意的是,发酵培养基的组成是按最终体积来计算的。比如20L的培养物就包括:18L的1B12改良培养基+2L的G52种子液,也就是说20L的发酵液只含有18L的发酵培养基。Generally, the inoculation amount of the seed liquid is 10% (V/V), and that of the fermentation liquid is 20% (V/V). It should be noted that the composition of the fermentation medium is calculated according to the final volume. For example, 20L of culture includes: 18L of 1B12 modified medium + 2L of G52 seed liquid, that is to say, 20L of fermentation broth only contains 18L of fermentation medium.
实施例Example
1、菌种的活化:从-80℃冰箱中取出纤维堆囊菌DSM11999,首先将菌种置于冰水中使之缓慢升温溶化,取1ml转入10ml的G52培养基中(置50ml摇瓶)培养3天,180rpm,30℃,摇瓶位移25mm。然后取5ml此G52培养物转入45ml的G52培养基中(置200ml摇瓶)培养3天,180rpm,30℃,摇瓶位移25mm。再取50ml的G52培养物转入450ml的G52培养基中(置2L摇瓶)培养3天,180rpm,30℃,摇瓶位移50mm。培养基G52为:干酵母粉2g/L,MgSO4 1g/L,CaCl21g/L,脱脂奶粉2g/L,马铃薯淀粉8g/L,无水葡萄糖2g/L,EDTA-Fe(III)-Na 1ml/L,调pH至7.4,120℃灭菌20分钟;1. Activation of strains: Take out S. cellulosus DSM11999 from the -80°C refrigerator, first place the strains in ice water to slowly heat up and dissolve, take 1ml and transfer to 10ml of G52 medium (put in a 50ml shake flask) Cultivate for 3 days, 180 rpm, 30°C, shake flask displacement 25mm. Then take 5 ml of this G52 culture and transfer it to 45 ml of G52 medium (put in a 200 ml shake flask) and cultivate for 3 days, 180 rpm, 30° C., and the shake flask is displaced by 25 mm. Then take 50 ml of G52 culture and transfer it to 450 ml of G52 medium (in a 2L shake flask) for 3 days, 180 rpm, 30° C., and the displacement of the shake flask is 50 mm. Medium G52 is: dry yeast powder 2g/L, MgSO 4 1g/L, CaCl 2 1g/L, skimmed milk powder 2g/L, potato starch 8g/L, anhydrous glucose 2g/L, EDTA-Fe(III)- Na 1ml/L, adjust the pH to 7.4, and sterilize at 120°C for 20 minutes;
2、维持培养:取50ml的上述培养物加入到450ml的G52培养基中(在2升的摇瓶中)培养。2. Maintenance culture: Take 50 ml of the above-mentioned culture and add it to 450 ml of G52 medium (in a 2-liter shake flask) for culture.
3、摇瓶中前培养:1×450ml的G52培养基(置于2升摇瓶中)接入50ml的维持培养物,培养4天,180rpm,30℃,pH7.4,摇瓶位移50mm。目的在于活化菌种,培育菌种。3. Pre-cultivation in shake flasks: 1 × 450ml of G52 medium (placed in a 2-liter shake flask) was inserted into 50ml of maintenance culture, cultured for 4 days, 180rpm, 30°C, pH7.4, shake flask displacement 50mm. The purpose is to activate the strains and cultivate the strains.
4、中间培养:90升的G52培养基置于150升的发酵槽中,接入10升的前培养物,培养4天,培养条件为:30℃,250rpm,通风量为每升液体培养基每分钟0.5升空气,121℃,pH7.4。目的在于使菌种达到对数生长期,为接下来的发酵培育做好准备。4. Intermediate culture: 90 liters of G52 medium is placed in a 150 liter fermenter, and 10 liters of pre-culture is inserted, and cultivated for 4 days. The culture conditions are: 30 ° C, 250 rpm, and the ventilation rate is per liter of liquid medium 0.5 liters of air per minute, 121°C, pH 7.4. The purpose is to make the strain reach the logarithmic growth phase and prepare for the next fermentation.
5、发酵培养:发酵在750L的发酵罐中进行,加入350升灭菌的1B12改良培养基和50升灭菌的2-羟丙基-β-环式糊精溶液(含2-羟丙基-β-环式糊精5000g),然后接入100升的中间培养物。此培养持续6天,培养条件为:25℃,180rpm,pH7.8。在发酵的第三天加入4mg/L丙氨酸和4mg/L乙酸钾。1B12改良培养基为:马铃薯淀粉20g/L,胰蛋白胨11g/L,MnCl4 1mg/L,K2HPO4 0.06/L;ZnCl21mg/L,CuSO41 mg/L,EDTA-Fe(III)-Na 8mg/L,调pH至7.8,120℃灭菌20分钟。5. Fermentation culture: Fermentation is carried out in a 750L fermenter, and 350 liters of sterilized 1B12 improved medium and 50 liters of sterilized 2-hydroxypropyl-β-cyclodextrin solution (containing 2-hydroxypropyl - β-cyclodextrin 5000 g), then inoculate 100 liters of intermediate culture. The culture lasted for 6 days, and the culture conditions were: 25°C, 180 rpm, pH 7.8. On the third day of fermentation, 4 mg/L alanine and 4 mg/L potassium acetate were added. 1B12 modified medium is: potato starch 20g/L, tryptone 11g/L, MnCl 4 1mg/L, K 2 HPO 4 0.06/L; ZnCl 2 1mg/L, CuSO 4 1 mg/L, EDTA-Fe(III )-Na 8mg/L, adjust the pH to 7.8, and sterilize at 120°C for 20 minutes.
6、产物的分离纯化:①500升的发酵物经离心、过滤,得到的发酵液与树脂按体积比65∶1,搅拌2h,产物从环式糊精中转移到树脂中,离心,得到的树脂先用12升的去离子水洗涤解吸附,然后用异丙醇洗涤2次,使产物转移到有机相,每次用30升的异丙醇搅拌30min,得到的洗涤液中加入水,萃取其中的异丙醇,剩下的水相中再用乙酸乙酯萃取3次,得到的乙酸乙酯萃取物在真空旋转蒸发器中浓缩、干燥,即可得粗结晶。6. Separation and purification of the product: ① 500 liters of fermented product was centrifuged and filtered, and the obtained fermentation broth and resin were mixed at a volume ratio of 65:1, stirred for 2 hours, and the product was transferred from the cyclodextrin to the resin, centrifuged, and the obtained resin First wash and desorb with 12 liters of deionized water, then wash twice with isopropanol, transfer the product to the organic phase, stir with 30 liters of isopropanol for 30 minutes each time, add water to the obtained washing solution, and extract it isopropanol, the remaining water phase was extracted with ethyl acetate three times, and the obtained ethyl acetate extract was concentrated and dried in a vacuum rotary evaporator to obtain crude crystals.
②以上获得的粗结晶悬浮于1ml异丙醇中,于25℃振荡24小时,过滤之后,在真空干燥器中干燥,得到epothilones B的白色晶体。epothilone B中还含有少量的epothilone A,可以进一步通过反相色谱柱RP-18柱来纯化,乙腈作为洗脱液。最后,用乙酸乙酯∶甲苯=2∶3的混合液来结晶,即可得到epothiloneA。②The crude crystals obtained above were suspended in 1ml of isopropanol, shaken at 25°C for 24 hours, filtered, and dried in a vacuum desiccator to obtain white crystals of epothilones B. Epothilone B also contains a small amount of epothilone A, which can be further purified by reverse-phase chromatography column RP-18, with acetonitrile as the eluent. Finally, crystallize with ethyl acetate:toluene=2:3 mixture to obtain epothiloneA.
对比例comparative example
同样采用纤维堆囊菌DSM11999,按照实施例的生产方法生产epothilones。不同之处有三点:一、不使用1B12改良培养基,改为使用1B12培养基;二、不添加糊精;三、不添加丙氨酸和乙酸钾。Also adopt S. cellulosus DSM11999 to produce epothilones according to the production method of the examples. There are three differences: 1. Instead of using 1B12 modified medium, 1B12 medium is used instead; 2. Dextrin is not added; 3. Alanine and potassium acetate are not added.
对实施例和对比例的产物进行分析:The product of embodiment and comparative example is analyzed:
每个摇瓶中添加2%(V/V)XAD-16树脂,180rpm摇2h。使树脂充分吸附培养物中的产物。然后用150um的尼龙筛过滤,过滤后的树脂用少许水洗涤,水是极性溶剂,用水洗涤可以解吸附树脂中的产物,洗涤液装入容器。Add 2% (V/V) XAD-16 resin to each shake flask, shake at 180rpm for 2h. Allow the resin to fully absorb the product in the culture. Then use a 150um nylon sieve to filter, and the filtered resin is washed with a little water. Water is a polar solvent. Washing with water can desorb the product in the resin, and the washing solution is loaded into a container.
再用60ml异丙醇(>99%)洗涤树脂,滤液装入密封管中,于室温下在Rota-Mixer(Labinco BV,Netherlands)上摇3min,然后取2ml液体,离心,取上清液用于HPLC。Then wash the resin with 60ml of isopropanol (>99%), put the filtrate into a sealed tube, and shake it on a Rota-Mixer (Labinco BV, Netherlands) for 3min at room temperature, then get 2ml of liquid, centrifuge, and get the supernatant for use in HPLC.
HPLC结果:将实施例所得到的粗晶体溶于1ml异丙醇,浓缩,采用HPLC分析可知epothilones产量为16.2mg/L;将对比例所得到的粗晶体溶于1ml异丙醇,浓缩,采用HPLC分析可知epothilones产量为11mg/L。可见,采用本发明的生产方法所得到的epothilones产量比采用原有方法的产量提高了47.3%。HPLC result: the thick crystal that the embodiment is obtained is dissolved in 1ml isopropanol, concentrates, adopts HPLC analysis to know that epothilones output is 16.2mg/L; The thick crystal that comparative example obtains is dissolved in 1ml isopropanol, concentrates, adopt HPLC analysis showed that the yield of epothilones was 11mg/L. It can be seen that the yield of epothilones obtained by the production method of the present invention is 47.3% higher than that of the original method.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101003385A CN1312286C (en) | 2005-10-19 | 2005-10-19 | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101003385A CN1312286C (en) | 2005-10-19 | 2005-10-19 | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1769468A true CN1769468A (en) | 2006-05-10 |
| CN1312286C CN1312286C (en) | 2007-04-25 |
Family
ID=36751012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101003385A Expired - Fee Related CN1312286C (en) | 2005-10-19 | 2005-10-19 | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1312286C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102093378A (en) * | 2010-12-21 | 2011-06-15 | 山东轻工业学院 | Method for efficiently desorbing Epothilone from adsorbent resin |
| CN102586358A (en) * | 2012-01-11 | 2012-07-18 | 湖北宏中药业有限公司 | Biosynthesis method for improving yield of epothilone B |
| CN105200093A (en) * | 2015-11-09 | 2015-12-30 | 山东大学 | Fermentation additive capable of changing generation rate of epothilone compound and improving yield of epothilone A |
| CN105200090A (en) * | 2015-11-12 | 2015-12-30 | 山东大学 | Culture medium for preparing epothilone through fermenting myxococcus Xanthus for heterologously expressing epothilone gene |
| CN115181703A (en) * | 2022-07-18 | 2022-10-14 | 江南大学 | A kind of solid medium for rapid growth of Micromonospora for the production of sisomicin |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101851591B (en) * | 2009-04-03 | 2011-12-21 | 上海医药工业研究院 | Fermentation method for producing epothilone B by sorangium cellulosum and fermentation medium |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (en) * | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilones, their production processes and agents containing these compounds |
| US6194181B1 (en) * | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| CN1212404C (en) * | 2002-02-07 | 2005-07-27 | 山东大学 | A kind of fermentation technology method that improves epothilone A output |
-
2005
- 2005-10-19 CN CNB2005101003385A patent/CN1312286C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102093378A (en) * | 2010-12-21 | 2011-06-15 | 山东轻工业学院 | Method for efficiently desorbing Epothilone from adsorbent resin |
| CN102586358A (en) * | 2012-01-11 | 2012-07-18 | 湖北宏中药业有限公司 | Biosynthesis method for improving yield of epothilone B |
| CN102586358B (en) * | 2012-01-11 | 2013-06-12 | 湖北宏中药业有限公司 | Biosynthesis method for improving yield of epothilone B |
| CN105200093A (en) * | 2015-11-09 | 2015-12-30 | 山东大学 | Fermentation additive capable of changing generation rate of epothilone compound and improving yield of epothilone A |
| CN105200093B (en) * | 2015-11-09 | 2018-08-03 | 山东大学 | A kind of additives for ferment that can change epothilones generation ratio and improve ebomycin A yield |
| CN105200090A (en) * | 2015-11-12 | 2015-12-30 | 山东大学 | Culture medium for preparing epothilone through fermenting myxococcus Xanthus for heterologously expressing epothilone gene |
| CN105200090B (en) * | 2015-11-12 | 2018-08-03 | 山东大学 | A kind of Myxococcus xanthus fermentation for heterogenous expression Epothilones gene prepares the culture medium of Epothilones |
| CN115181703A (en) * | 2022-07-18 | 2022-10-14 | 江南大学 | A kind of solid medium for rapid growth of Micromonospora for the production of sisomicin |
| CN115181703B (en) * | 2022-07-18 | 2023-10-27 | 江南大学 | A solid medium for rapid growth of Micromonospora for the production of sisomicin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1312286C (en) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5729919B2 (en) | Thiacomycin production | |
| EP1054994B1 (en) | Fermentative preparation process for cytostatics and crystal forms thereof | |
| AU2003275068B2 (en) | Methods for the preparation, isolation and purification of epothilone B, and X-Ray crystal structures of epothilone B | |
| CN102140485B (en) | Method for preparing acarbose through microbial fermentation | |
| CN102399837B (en) | Method for synthesizing acarbose through microbial fermentation | |
| CN1867664A (en) | Production of tacrolimus (fk-506) using new streptomyces species | |
| WO2010058427A2 (en) | Process for production and purification of polymyxin b sulfate | |
| CN1312286C (en) | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum | |
| CN1840684A (en) | Method for producing nosipeptide by fermenting streptomyces | |
| CN1367255A (en) | Fermentation process for raising ebomycin A yield | |
| CN1449399A (en) | Polycyclic xanthones as antibiotics | |
| CN1190497C (en) | Preparation technology of geldanamycin and its derivative | |
| CN1158298C (en) | Antineoplastic compound and its prepn and medicinal use | |
| CN104250621A (en) | Sea streptomyces cinereoruber and method of applying same to prepare aurone compound | |
| CN1306024C (en) | Fungus and method for preparing vanillin from isoeugenol converted by microorgan | |
| CN101074234A (en) | Antitumor antibiotics and its production | |
| CN102399848A (en) | Method and application of improving epothilone fermentation yield by using competitive microorganisms | |
| CN102952760B (en) | A strain of Rhodococcus erythropolis capable of converting quinine into (S)-3-quinine alcohol and its transformation method | |
| CN102559556B (en) | Fermentation method for improving quinoxalone yield | |
| CN1217929C (en) | Acomycin, its production process and its use as medicine | |
| CN1830994A (en) | Protopanaxatriol derivatives and their preparation methods and applications | |
| CN1071950A (en) | New antitumor antibiotics | |
| CN1259330C (en) | Heptaene macrolide polyketone antibiotic FR-008 compound | |
| CN1225467C (en) | Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method | |
| CN103937867B (en) | A method for splitting racemate β-lactam with whole cells of Bradyrhizobium soybean |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070425 Termination date: 20121019 |